Treatment of acute lymphoblastic leukemia

N Engl J Med. 2006 Jan 12;354(2):166-78. doi: 10.1056/NEJMra052603.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Asparaginase / therapeutic use
  • Central Nervous System Neoplasms / therapy
  • Child
  • Combined Modality Therapy
  • Dexamethasone / therapeutic use
  • Gene Expression Profiling
  • Humans
  • Methotrexate / therapeutic use
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / radiotherapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Prognosis
  • Remission Induction / methods
  • Risk Assessment
  • Stem Cell Transplantation
  • Survival Analysis

Substances

  • Anti-Inflammatory Agents
  • Dexamethasone
  • Asparaginase
  • Methotrexate